Objective:Obesity is associated with delayed insulin absorption upon subcutaneous (s.c.) dosing in humans. The aim of this study was to investigate whether alterations in depot structure and kinetics of the s.c. injection depot could contribute to this delay. Methods:Rats fed a high-fat diet (HFD) and low-fat diet (LFD) were included in a series of insulin pharmacokinetic and imaging studies. Injection depots were visualized with μCT imaging upon s.c. dosing with insulin aspart mixed with the contrast agent iomeprol, and insulin aspart exposure was measured by means of Luminescent Oxygen Channeling Immunoassay.Results:Body weight and fat mass was increased in rats fed a HFD vs. LFD (p<0.05), whereas the lean mass was not. The HFD group exhibited delayed insulin absorption from the s.c. tissue (p<0.001). This delay was associated with smaller injection depots upon s.c. dosing (p<0.05) and correlated with a slower depot disappearance from the s.c. tissue (p<0.05) compared to the LFD group. Depot disappearance from the s.c. tissue was inversely correlated with body fat mass (p<0.05). Conclusions:Alterationsin s.c. injection depot structure and kinetics may play a role in the obesity-associated delay in insulin absorption.